This course is designed to provide the tools for participants to enhance interpretation skills utilizing the latest imaging technologies. Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in Cardiovascular imaging.
At the conclusion of this activity, participants should better be able to:
• Outline CT protocols and techniques for improved clinical diagnosis of diseases of the cardiovascular system.
• Integrate information presented in this course into efforts to improve the imaging skills of the participants
Geoff Rubin, MD, MBA, FACR, FAHA, FSABI, FNASCI
•Chair of Medical Imaging
•Professor of Radiology and Bioengineering
•University of Arizona, Tucson, Arizona
Dr. Rubin is Past President of the North American Society for Cardiovascular Imagers, the Society for Computed Body Tomography and Magnetic Resonance, and the Fleischner Society for Thoracic Imaging and Diagnosis. He is the author of over 200 peer-reviewed manuscripts and over 50 review articles and book chapters.
Cardiovascular Imaging - Geoff Rubin, M.D.
3.25 AMA PRA Category 1 Credit(s)™
Refund Policy: Cancellations can only be made within 24 hours of purchase. Please note: If you have applied for CME credit during the 24 hour period “NO” refunds will be available. Refunds will be given less a $100.00 administrative fee.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CME Science. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty members have nothing to disclose.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CME Science planners and managers have nothing to disclose.
Method of Participation and Request for Credit
During the period Dec 29, 2021 through Dec 29, 2023, participants must read the learning objectives and faculty disclosures and study the educational activity.
Computer System Requirements
Any online accessible device.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.